Director TitleAgeSince
Director/Board Member - 30/09/2010
Director/Board Member - 30/09/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
-0.05%-0.38%+53.18%+67.54% 388B
-0.78%+5.51%+72.55%+44.25% 366B
+0.78%+2.95%+33.25%+59.08% 303B
-0.04%+8.08%+12.08%+34.94% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average +17,989.92%+4.59%+45.39%+79.44% 469.63B
Weighted average by Cap. -0.14%+5.30%+49.28%+93.75%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock